Clinical Trial

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 18, 2025 (before its estimated September 19, 2025 completion). Its status may not reflect the trial's current state.
Summary
Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-08; most recent amendment 2025-09-12.
Trial Details
NCT Number NCT06591377
Lead Sponsor Kafrelsheikh University
Collaborators: El-Sahel Teaching Hospital
Conditions Ischemic Stroke
Enrollment 900 participants
Start Date 2024-08-10
Primary Completion 2025-09-19 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-18